reference/28368571

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28368571

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	141
issn	1178-1661 1178-1653
issueIdentifier	1
pageRange	131-141
publicationName	The Patient - Patient-Centered Outcomes Research
startingPage	131
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5d012cfae6e8b67d8437e7145ea9a68f
bibliographicCitation	Wu Y, Hirsh V, Sequist LV, Hu C, Feng J, Lu S, Huang Y, Schuler M, Mok T, Yamamoto N, O’Byrne K, Geater SL, Zhou C, Massey D, Märten A, Lungershausen J, Yang JC. Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6). The Patient - Patient-Centered Outcomes Research. 2017 Nov 24;11(1):131–41. doi: 10.1007/s40271-017-0287-z.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8661ed976a1d46c09c1ea82578698d74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a90bc9631ea73804455af97ed4292ea1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1402710a016550b01be820f81f6b10f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65e5d6973c2e5e86c85411fe434fdd80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8801456b086a068a5b1545507d44380e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f4385ffe6f2b7bc52fbc1a61037d516 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81819c8c559f32b7d547278a300a9e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90f79564faf4962e807814828fb5f3d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f490d8edfe4337ec7abba6c48734b11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98b0de0cf6408e365af368a48806b435 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b4a849344bd1bc5c7dd3a543b13770a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67f01922096949778d955308e78ab4b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_445c654b648495d3b87dbcd7fd58361d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f2f201caceb57b0739887993774fed6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f1f67e5fa4c14dc4b714d3d063c8fef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_826fe2be8f9341d4c791d01baad591a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f9e1f0380ae5a370e136985dcbc4ae5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5586-5138
date	2017-11-24^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/29178024 https://doi.org/10.1007/s40271-017-0287-z https://pubmed.ncbi.nlm.nih.gov/PMC5766712
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36646 https://portal.issn.org/resource/ISSN/1178-1661 https://portal.issn.org/resource/ISSN/1178-1653
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6)
discusses	http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0561143
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D066246Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D006304 http://id.nlm.nih.gov/mesh/D000071066 http://id.nlm.nih.gov/mesh/D000077716 http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D008175Q000503 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D002289Q000503
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7353 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 71 of 71.